Action Point Financial Planning’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13
Closed -$659 – 2320
2026
Q2
$659 Buy
+13
New +$532 ﹤0.01% 2589

Other funds holding TGTX

Action Point Financial Planning's TGTX Position: Q3 2026 in Review

Action Point Financial Planning sold out of TG Therapeutics (TGTX) in Q3 2026, closing a stake of 13 shares — an estimated $659 sold.

Action Point Financial Planning first reported a position in TGTX in Q2 2026 and held it in 1 quarter. The position peaked at $659 in Q2 2026. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Action Point Financial Planning reported no remaining TG Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 13 TG Therapeutics shares in Q3 2026, an estimated $659.
  • Action Point Financial Planning first reported a position in TG Therapeutics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's TG Therapeutics position peaked at $659 in Q2 2026.
  • 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.